ArticleCureus2026
Goltz-Gorlin Syndrome: A Case Report and Literature Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Goltz-Gorlin syndrome, also known as focal dermal hypoplasia (FDH), is an uncommon X-linked dominant mesoectodermal dysplasia that predominantly affects females, with most nonmosaic males presumed to be nonviable. The disorder arises from abnormal development of mesodermal and ectodermal tissues and manifests as a broad spectrum of multisystem abnormalities. It is characterized by distinctive cutaneous findings and extracutaneous involvement involving the ocular, dental, skeletal, GI, genitourinary, cardiovascular, and central nervous systems. We report the case of a 49-year-old woman who presented with multiple papillomatous lesions initially involving the oral cavity and progressively spreading to other areas. Physical examination revealed innumerable millimetric verruciform papules, as well as multiple soft, yellowish, smooth oval papules over a hyperpigmented macule distributed along Blaschko lines. Additional findings included telangiectasias, patchy alopecia, dental anomalies, strabismus, and syndactyly/ectrodactyly of the left hand and right foot. Histopathological examination of verruciform and yellow papules confirmed FDH. PCR testing for human papillomavirus from oral and heel lesions was negative. The diagnosis of Goltz-Gorlin syndrome was established based on clinical criteria and histopathological findings. Multidisciplinary management included dental excision of papillomas and treatment with topical 5-fluorouracil and oral isotretinoin, resulting in complete remission. To date, approximately 200-300 cases have been reported worldwide. A retrospective institutional review identified only two additional cases between 2010 and 2025, underscoring the rarity of this condition. This case highlights the importance of early recognition of Goltz-Gorlin syndrome through characteristic cutaneous and extracutaneous findings and suggests that combined topical 5-fluorouracil and oral isotretinoin may be an effective therapeutic option for extensive papillomatous lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.